142 related articles for article (PubMed ID: 9882033)
1. Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Bisso G; Pivari M; Vigneri S; Termini R; Fiorucci S; Usai P; Malesci A; Celle G
Aliment Pharmacol Ther; 1998 Dec; 12(12):1241-7. PubMed ID: 9882033
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.
Tutuian R; Katz PO; Bochenek W; Castell DO
Aliment Pharmacol Ther; 2002 Apr; 16(4):829-36. PubMed ID: 11929403
[TBL] [Abstract][Full Text] [Related]
3. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
[TBL] [Abstract][Full Text] [Related]
4. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients.
Müller P; Simon B; Khalil H; Lühmann R; Leucht U; Schneider A
Z Gastroenterol; 1992 Nov; 30(11):771-5. PubMed ID: 1471382
[TBL] [Abstract][Full Text] [Related]
5. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
Metz DC; Pratha V; Martin P; Paul J; Maton PN; Lew E; Pisegna JR
Am J Gastroenterol; 2000 Mar; 95(3):626-33. PubMed ID: 10710049
[TBL] [Abstract][Full Text] [Related]
6. Acid suppression in healthy subjects following lansoprazole or pantoprazole.
Huang JQ; Goldwater DR; Thomson AB; Appelman SA; Sridhar S; James CF; Chiu YL; Pilmer BL; Keith RG; Hunt RH
Aliment Pharmacol Ther; 2002 Mar; 16(3):425-33. PubMed ID: 11876695
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
8. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
Koop H; Kuly S; Flüg M; Eissele R; Mönnikes H; Rose K; Lühmann R; Schneider A; Fischer R; Arnold R
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):915-8. PubMed ID: 8889461
[TBL] [Abstract][Full Text] [Related]
9. Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients.
Pazzi P; Scagliarini R; Gamberini S; Matarese V; Rizzo C; Gullini S
Aliment Pharmacol Ther; 1998 Aug; 12(8):731-4. PubMed ID: 9726385
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.
Judmaier G; Koelz HR
Aliment Pharmacol Ther; 1994 Feb; 8(1):81-6. PubMed ID: 8186350
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
12. Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
Goldstein JL; Miner PB; Schlesinger PK; Liu S; Silberg DG
Aliment Pharmacol Ther; 2006 Apr; 23(8):1189-96. PubMed ID: 16611280
[TBL] [Abstract][Full Text] [Related]
13. The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery.
Memiş D; Turan A; Karamanlioglu B; Saral P; Türe M; Pamukçu Z
Anesth Analg; 2003 Nov; 97(5):1360-1363. PubMed ID: 14570652
[TBL] [Abstract][Full Text] [Related]
14. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole.
Hartmann M; Ehrlich A; Fuder H; Lühmann R; Emeklibas S; Timmer W; Wurst W; Lücker PW
Aliment Pharmacol Ther; 1998 Oct; 12(10):1027-32. PubMed ID: 9798809
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
[TBL] [Abstract][Full Text] [Related]
16. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Burkhardt F
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.
Florent C; Forestier S
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.
Geus WP; Mathôt RA; Mulder PG; Lamers CB
Aliment Pharmacol Ther; 2000 Aug; 14(8):1057-64. PubMed ID: 10930900
[TBL] [Abstract][Full Text] [Related]
20. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
